These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 4139875)

  • 1. Bone marrow transplantation in inbred strains of mice. I. The failure of development of normal T cell function following allogeneic transplantation.
    Trier L; Rubin B
    Acta Pathol Microbiol Scand B Microbiol Immunol; 1974 Oct; 82B(5):724-32. PubMed ID: 4139875
    [No Abstract]   [Full Text] [Related]  

  • 2. Adaptive phenomena in bone marrow transplantation.
    Goujet-Zalc C; Ilbery PL
    Exp Hematol; 1973; 1(1):3-10. PubMed ID: 4154047
    [No Abstract]   [Full Text] [Related]  

  • 3. Bone marrow transplantation across the major histocompatibility barrier in specific-pathogen-free mice: effects of intact versus T cell-depleted bone marrow on the expression of anti-host reaction in the recipient spleens.
    Muto M; Sado T; Aizawa S; Kamisaku H; Kubo E
    J Immunol; 1981 Dec; 127(6):2421-5. PubMed ID: 6457876
    [No Abstract]   [Full Text] [Related]  

  • 4. The detection of theta antigen on cells by immunofluorescence: failure to detect theta antigen on rosette-forming cells.
    Russell SM; Ferrarini M; Munro A; Lachmann PJ
    Eur J Immunol; 1972 Oct; 2(5):456-9. PubMed ID: 4563571
    [No Abstract]   [Full Text] [Related]  

  • 5. [Mouse rosette forming cells in transplantation immunity].
    Brondz BD; Eliseeva LS; Kotomina IF; Egorova SG
    Tsitologiia; 1974 Jan; 16(1):74-81. PubMed ID: 4142816
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunosuppression and malignant lymphomas in graft-versus-host reactions.
    Solnik C; Gleichmann H; Kavanah M; Schwartz RS
    Cancer Res; 1973 Sep; 33(9):2068-77. PubMed ID: 4146854
    [No Abstract]   [Full Text] [Related]  

  • 7. Antilymphocytic antibodies and marrow transplantation. V. Suppression of secondary disease by host-versus-theta-graft reaction.
    Thierfelder S; Rodt H
    Transplantation; 1977 Jan; 23(1):87-92. PubMed ID: 319574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Suppression of antibody formation by bone marrow T-cells activated by histocompatibility antigens].
    Gambarov SS; Khaitov RM
    Biull Eksp Biol Med; 1977 Mar; 83(3):300-2. PubMed ID: 322761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delayed secondary disease in mice after early or late therapy with anti-thymocyte serum.
    Kinnamon KE; Blackwell LH; Ledney GD
    Exp Hematol; 1973; 1(4):202-14. PubMed ID: 4154088
    [No Abstract]   [Full Text] [Related]  

  • 10. Antilymphocytic antibodies and marrow transplantation. IV. Comparison of the effects of antibody fragments directed against immunoglobulin or lymphocyte antigens on acute secondary disease.
    Rodt H; Therfelder S; Eulitz M
    Exp Hematol; 1974; 2(4):195-203. PubMed ID: 4156327
    [No Abstract]   [Full Text] [Related]  

  • 11. Progress in the prevention of GVH: bone marrow grafts after ALG conditioning, with lymphocyte split chimerism, use of a lymphocyte "chalone T", and soluble histocompatibility antigens.
    Mathé G; Kiger N; Florentin I; Garcia-Giralt E; Martyre MC; Halle-Pannenko O; Schwartzenberg L
    Transplant Proc; 1973 Mar; 5(1):933-9. PubMed ID: 4144474
    [No Abstract]   [Full Text] [Related]  

  • 12. Donor antigen-presenting cells regulate T-cell expansion and antitumor activity after allogeneic bone marrow transplantation.
    Li JM; Waller EK
    Biol Blood Marrow Transplant; 2004 Aug; 10(8):540-51. PubMed ID: 15282532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro modification of donor bone marrow used to produce enhanced graft survival in antilymphocyte serum (ALS)-treated mice.
    Gozzo JJ; Wood ML; Pompei R; Monaco AP
    Transplant Proc; 1973 Mar; 5(1):853-6. PubMed ID: 4572148
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of the treatment of parental cells in vitro with anti-T antibody on bone marrow transplantation in F1 hybrid mice.
    Hrubá A; Paluska E; Fricová V; Fiala J
    Folia Biol (Praha); 1980; 26(5):338-50. PubMed ID: 7002637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Separation of mouse spleen haematopoietic cell fractions for transplantation purposes in lethally irradiated mice.
    Fiala J; Viktora L; Fricová V; Hrubá A; Pristoupil TI
    Physiol Bohemoslov; 1975; 24(3):275-81. PubMed ID: 238253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beneficial influence of limited histocompatibility of bone marrow grafted to unrelated rhesus monkeys preconditioned with x-ray and ALS.
    Neffe JR; Merritt CB; Darrow CC; Rogentine GN
    Transplant Proc; 1974 Jun; 6(2):125-8. PubMed ID: 4208750
    [No Abstract]   [Full Text] [Related]  

  • 17. Of mice and men in bone marrow transplantation.
    Mathé G; Schwarzenberg L; Halle-Pannenko O; Abuaf N; Pouillart P
    Transplant Proc; 1977 Mar; 9(1):155-68. PubMed ID: 17189
    [No Abstract]   [Full Text] [Related]  

  • 18. Bone marrow transplantation across major histocompatability barriers in mice. III. Treatment of donor grafts with monoclonal antibodies directed against Lyt determinants.
    Vallera DA; Soderling CC; Kersey JH
    J Immunol; 1982 Feb; 128(2):871-5. PubMed ID: 6172513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of iodoacetate on the bone marrow immunocompetence of AKR mice.
    Rheins MS; Filppi JA; Moore VS
    Cancer Res; 1975 Jun; 35(6):1514-9. PubMed ID: 1093673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T cell suppression in vitro. I. Role in regulation of antibody responses.
    Feldmann M
    Eur J Immunol; 1974 Oct; 4(10):660-6. PubMed ID: 4547708
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.